Serum plasminogen activator inhibitor-1 levels in patients with major depressive disorder vs. healthy controls: a systematic review and meta-analysis

Serum plasminogen activator inhibitor-1 levels in patients with major depressive disorder vs. healthy controls: a systematic review and meta-analysis

Abstract Introduction Major depressive disorder (MDD) is a severe mental health condition that affects millions of people worldwide. Etiologically, several factors may play a role in its development. Previous studies have reported elevated plasminogen activator inhibitor-1 (PAI-1) levels in patien...

Full description

Bibliographic Details
Main Authors:	Mohamed Elsayed, Khaled A. Mohamed, Khaled T. Dardeer, Dalia K. Zaafar, Soha Osama Hassanin, Ramy Abdelnaby, Carlos Schönfeldt-Lecuona
Format:	Article
Language:	English
Published:	Associação de Psiquiatria do Rio Grande do Sul 2023-08-01
Series:	Trends in Psychiatry and Psychotherapy
Subjects:	Plasminogen activator inhibitor-1 SERPINE1 major depression meta-analysis tissue plasminogen activator BDNF
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2237-60892023000100303&lng=en&tlng=en

Similar Items

Plasminogen interaction with Trypanosoma cruzi
by: Laura Almeida, et al.
Published: (2004-02-01)

Characterization of plasmin, plasminogen and plasminogen activator in goat milk
by: F. Polidori, et al.
Published: (2011-03-01)

Lack of durable protection against cotton smoke-induced acute lung injury in sheep by nebulized single chain urokinase plasminogen activator or tissue plasminogen activator
by: Satoshi Fukuda, et al.
Published: (2018-06-01)

The plasminogen activating system in the pathogenesis of Alzheimer’s disease
by: Manuel Yepes
Published: (2021-01-01)

Hemostasis System and Plasminogen Activity in Retrochorial Hematoma in the First Trimester of Pregnancy
by: Natalia B. Tikhonova, et al.
Published: (2022-09-01)

Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19
by: Tetiana Yatsenko, et al.
Published: (2024-01-01)

Corrigendum: Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19
by: Tetiana Yatsenko, et al.
Published: (2024-03-01)

Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors
by: Lampelj Maja, et al.
Published: (2015-12-01)

Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
by: Niaz Mahmood, et al.
Published: (2018-02-01)

Annexin A2-Mediated Plasminogen Activation in Endothelial Cells Contributes to the Proangiogenic Effect of Adenosine A2A Receptors
by: María D. Valls, et al.
Published: (2021-04-01)

Fibrinolysis regulation by platelets retaining plasminogen and tissue-type plasminogen activator on their surface
by: T. Grinenko, et al.
Published: (2019-12-01)

Association between Plasma Levels of Plasminogen Activator Inhibitor-1 and Colorectal Neoplasms
Published: (2013-09-01)

Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
by: Nurbadriah binti Jasmiad, et al.
Published: (2022-09-01)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin′s Lymphoma
by: Shirin Kouhpayeh, et al.
Published: (2017-01-01)

A novel ex vivo approach for measuring plasminogen activation upon established plasma clots
by: Jason S. Palazzolo, et al.
Published: (2022-07-01)

Study of the sites of plasminogen molecule which are responsible for inhibitory effect of Lys-plasminogen on platelet aggregation
by: Y. M. Roka-Moya, et al.
Published: (2014-10-01)

Modulation of staphylokinase-dependent plasminogen activation by mono- and divalent ions
by: Yarzábal A., et al.
Published: (1999-01-01)

Precision targeting of the plasminogen activator inhibitor‐1 mechanism increases efficacy of fibrinolytic therapy in empyema
by: Galina Florova, et al.
Published: (2021-05-01)

Assessment of plasminogen activator inhibitor-1 in obese Egyptian children
by: Marwa Farouk Mira, et al.
Published: (2020-01-01)

Origin and diversification of the plasminogen activation system among chordates
by: Andrés Chana-Muñoz, et al.
Published: (2019-01-01)

Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatments
by: Hélène Party, et al.
Published: (2019-10-01)

Plasminogen Activator – Multifunctional Protein of Plague Pathogen
by: L. M. Kukleva, et al.
Published: (2016-09-01)

Parvalbumin interneuron-derived tissue-type plasminogen activator shapes perineuronal net structure
by: Matthieu Lépine, et al.
Published: (2022-10-01)

Haplotype analysis of SERPINE1 gene: Risk for aneurysmal subarachnoid hemorrhage and clinical outcomes
by: Mingkuan Lin, et al.
Published: (2019-08-01)

Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis
by: Toshiaki Iba, et al.
Published: (2017-09-01)

Plasminogen activator inhibitor-1 gene polymorphism as a risk factor for vascular complications in type 2 diabetes mellitus
by: Fatma A. Khalaf, et al.
Published: (2019-10-01)

Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients
by: Nader Nemr, et al.
Published: (2019-12-01)

Plasminogen activation in the musculoskeletal acute phase response: Injury, repair, and disease
by: Breanne H.Y. Gibson, et al.
Published: (2020-05-01)

Immunohistochemical study of the plasminogen activator system in benign epithelial odontogenic lesions
by: Carla Samily de Oliveira Costa, et al.
Published: (2022-05-01)

Immunohistochemical expression of plasminogen activator inhibitor-1 in subcutaneous versus omental adipose tissue in patients after elective abdominal surgery
by: Mehmet Yildiz, et al.
Published: (2019-10-01)

Decrease of fibrinolytic potential in the occurrence of cerebral ischemia
by: Vučković Biljana, et al.
Published: (2008-01-01)

ISOLATION AND PURIFICATION OF A KRINGLE 5 FROM HUMAN PLASMINOGEN USING AH-SEPHAROSE
by: Kapustianenko L. G., et al.
Published: (2014-08-01)

Local Production of Soluble Urokinase Plasminogen Activator Receptor and Plasminogen Activator Inhibitor‐1 in the Coronary Circulation Is Associated With Coronary Endothelial Dysfunction in Humans
by: Michel T. Corban, et al.
Published: (2018-08-01)

Single measurement of plasminogen activator inhibitor-1 in sepsis: is it useful for evaluating the severity or prognosis of sepsis?
by: Kansuke Koyama, et al.
Published: (2017-11-01)

Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma
by: Wen-Jing Liu, et al.
Published: (2018-01-01)

SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment
by: Ralf-Peter Czekay, et al.
Published: (2024-05-01)

Intravenous thrombolysis with rt-plasminogen activator in patients with acute ischemic stroke: clinical experience from two Egyptian centers
by: Nabil Mohamed, et al.
Published: (2020-01-01)

Roles of tissue plasminogen activator and its inhibitor in proliferative diabetic retinopathy
by: Shu-Ling Wu, et al.
Published: (2014-10-01)

The Effects of Regular Aerobic Exercise on the Serum levels of Plasminogen Activator Inhibitor-1 and Adiponectin in Obese Girls
by: Masoumeh Habibian, et al.
Published: (2019-12-01)

<i>N</i>-Alkylisatin-Loaded Liposomes Target the Urokinase Plasminogen Activator System in Breast Cancer
by: Lisa Belfiore, et al.
Published: (2020-07-01)